Human mesenchymal stem cells are potential agents for tissue regeneration, enhancing hematopoietic stem cell transplantation and delivering genes of therapeutic interest. To implement any of these strategies successfully, we need a better understanding of factors that influence the tissue distribution of systemically administered mesenchymal stem cells.
Introduction
Bone marrow-derived human mesenchymal stem cells (MSC) are an accessible population of progenitor cells that can differentiate into mesenchymal tissues including cartilage and bone 1 are easily expanded ex vivo and readily transduced by viral vectors. 2, 3 Human MSC may prove useful for enhancing hematopoietic stem cell transplantation, 4 modulating graft-versus-host disease, 5 treating disorders of bone, cartilage 6 and muscle 7 and delivering therapeutic genes. 8 The successful employment of human MSC for these in vivo strategies relies upon the efficient localization and retention of cells within appropriate tissues. Site-directed administration of MSC can result in successful engraftment and integration of MSC under specific circumstances, most commonly in injured tissue. [9] [10] [11] It remains unresolved to what degree such effects are due to the local production of growth factors rather than direct participation of injected MSC in cellular regeneration.
Site-directed administration is practicable only for a limited number of applications, hence the localization of systemically administered MSC in appropriate tissues, for example bone marrow, is crucial to the success of many therapies. The initial localization of circulating cells to specific organs is referred to as homing. Homing of hematopoietic stem and progenitor cells to the bone marrow is a multistep process mediated by adhesion molecules and chemokines. [12] [13] [14] [15] Far less is known about the in vivo homing of human MSC, partly because in vivo studies using systemic administration have employed different models and read-out systems. Evidence for tissue localization of systemically infused MSC is most convincing in models employing tissue injury. [16] [17] [18] Current evidence suggests that in the absence of tissue damage systemically administered MSC seed to the bone marrow only at low levels, [19] [20] [21] with large numbers of MSC lodging in the pulmonary vascular bed. Although MSC can engraft in non-pulmonary tissues, levels are at the limit of detection and of clinical use only in disorders such as osteogenesis imperfecta. 22 The initial localization of exogenously administered MSC to target tissues or organs is critical, and clearly we need a better understanding of the mechanisms that regulate the migration and homing of MSC to the bone marrow and other tissues in vivo. The chemokine stromal derived factor-1 (SDF-1) has a major role in the homing and engraftment of hematopoietic stem and progenitor cells to the bone marrow, 15 and together with its receptor, CXCR4, functions in stem cell seeding of the bone marrow during embryonic development. 24 Enforced expression of CXCR4 on CD34 + cells increased migration and engraftment in immunodeficient animals. 25 Levels of CXCR4 and SDF-1 are upregulated in stressed or injured tissues, 26, 27 hence this receptor/ligand pair may mediate metastatic invasion, 28 or the migration of cells into damaged tissues. 29, 30 Human MSC express low levels of CXCR4, 31, 32 which may account for the low levels of seeding to the bone marrow following systemic infusion. Despite low levels of CXCR4, human MSC are reported to migrate to SDF-1 in vitro, 31, 33, 34 suggesting that, like hematopoietic stem and progenitor cells, human MSC may upregulate functional CXCR4 molecules to the cell surface. Other factors important in MSC homing and migration in vivo include vascular endothelial growth factor, fibroblast growth factor-2, interleukin-6, hepatocyte growth factor and monocyte chemotactic protein-1. [34] [35] [36] Irradiation or tissue damage may increase MSC migration by inducing such factors. 37, 38 The present study was designed to investigate the short-term homing of bone marrow-derived human MSC using unconditioned B6.CB17-Prkdc-SzJ SCID (NOD/SCID) and β2m/NOD/SCID animals. The aim was to evaluate factors, including animal age and CXCR4 expression, which influence the short-term biodistribution of human MSC in this unconditioned xenogeneic animal model.
Design and Methods

Human mesenchymal stem cells isolation and culture
Human MSC were obtained from the bone marrow of healthy donors undergoing bone marrow harvest after informed consent under a protocol approved by the local ethics committee. Human MSC were cultured from the adherent fraction of bone marrow mononuclear cells, and characterized for phenotype and differentiation function according to established protocols, 39, 2 (see the Online Supplementary Methods).
Mice
B6.CB17-Prkdc-SzJ severe combined immunodeficiency (NOD/SCID) and β2-microglobulin non-obese diabetic/severe combined immunodeficiency (β2m NOD/SCID) mice were obtained from Jackson Laboratories and bred and maintained under defined flora conditions in individually ventilated sterile microisolater cages in accordance with the Animals Scientific Procedures Act 1986 approved by the Institutional Animal Care and Use and licensed by the Home Office. Mice underwent transplantation with MSC by lateral tail vein injection and were killed by CO2 inhalation 20-24 hours after transplantation. For irradiation experiments mice were sublethally irradiated (325 cGy from a cesium 137 source). Fluorescence in situ hybridization assay FISH was performed using probes specific for the human X and Y chromosomes. Human MSC of male origin were transplanted into female mice. FISH analysis was performed on mononuclear cell suspensions from bone marrow and other organs using standard techniques. (see the Online Supplementary Methods).
Labeling human mesenchymal stem cells with PKH-26 and injection into animals
Viral vector construction and transduction of human mesenchymal stem cells with CXCR4
Details of the bicistronic lentiviral vector containing cDNA for CXCR4 (Figure 1 ) are given in the Online Supplementary Methods. Human MSC at early passage (<3) were transduced using a multi-hit protocol as previously described 2 (see the Online Supplementary Methods).
Analysis of surface and intracellular CXCR4 expression
Human MSC were incubated with phycoerythrinconjugated anti-human CXCR4 (BD PharMingen) for 30 minutes on ice, washed and analyzed by flow cytometry. For intracellular CXCR4 staining, surface CXCR4 molecules were blocked with non-conjugated antihuman CXCR4 monoclonal antibody (10 µg/mL) for 1 hour on ice. Cells were washed, fixed, permeabilized (BD Cytofix/Cytoperm, BD Biosciences), and subsequently incubated with anti-human CXCR4-phycoerythrin monoclonal antibody. After further washing, cells were analyzed on an EPICS Elite flow cytometer (Beckman-Coulter).
In vitro migration assay
Recombinant human SDF-1 (0-100 ng/mL, Peprotech) was placed in the lower chamber of fibronectin-coated Transwell filters (8.0 µm Pore Size, Corning Inc). CXCR4-transduced, or control hMSC were plated in the upper chamber and allowed to migrate over 4 hours at 37°C. Filters were removed, fixed using 100% ice cold methanol (-20°C for 10 minutes) and washed once in phosphate-buffered saline. Filters were stained with hematoxylin and eosin, washed and air dried. Cells on the upper surface of each filter were carefully removed using a damp cotton bud, filters were detached, placed on a glass slide and mounted using DPX mounting medium. Migrated cells were visualized by light microscopy, and counted by two independent observers (20 fields per slide, x100 power).
Statistical analysis
Differences between groups were analyzed using the Mann-Whitney U test; p values less than 0.05 were considered statistically significant (GraphPad Prism Version 4.0).
Results
In vivo homing of human mesenchymal stem cells in unconditioned immunodeficient mice
PKH-26 (PKH)-labeled human MSC (1.5-2.0×10 6 cells/animal; for optimization of cell doses, see the Online Supplementary Methods) were administered via the tail vein into unconditioned β2m/NOD/SCID animals. Animals were sacrificed 20-24 hours later, and single cell suspensions from bone marrow, spleen, lungs and liver were analyzed for PKH-positive cells by flow cytometry. The highest levels of homing were consistently found in the lungs, while there was considerable variation of PKH-positive cells in the bone marrow and spleen between animals ( Figure 2A , Table 1 ). PKH-positive cells were also detected in the liver. In two experiments, homing was also analyzed at 48 hours, with similar results to those at 24 hours. There was some donorto-donor variation; this did not, however, correlate with donor age or sex. These findings were supported by FISH analysis using human X and Y specific probes (Online Supplementary Figure S1 ). PKH-positive cells identified in murine tissues also stained positive with a human-specific anti-HLA class I monoclonal antibody (data not shown). We also used unconditioned NOD/SCID animals as recipients. There was a generally lower level of homing in these animals than in β2m/NOD/SCID recipients (Table 1) .
Extended culture of cells is usually required to obtain sufficient numbers of human MSC for therapeutic applications. We studied the effect of passage number on homing behavior. The numbers of PKH-positive cells in the bone marrow of β2mNOD/SCID mice were lower in mice transplanted with advanced passage human MSC than in animals that had received cells from earlier passages (p<0.001, Figure 2B ). A similar effect of passage number was seen in the spleen (p<0.01).
Efficiency of short-term homing alters with the animals' age
The numbers of PKH-positive cells detected in the bone marrow of younger (<10 weeks) animals were significantly higher (median 433/10 5 ; range, 294-521) than the numbers in older (>10 weeks) animals (median, 166/10 5 ; range, 120-306; p<0.001, Figure 2C ). To control for any age-related changes in bone marrow cellularity we determined the numbers of PKH-positive cells per bone. This analysis confirmed that bone marrow homing was greater in younger (<10 weeks) animals (medi- an, 8836/bone; range, 4600-15977, vs median, 2725/bone; range, 1750-7933 in older animals; p<0.001). This effect of the animals' age was also observed for human MSC homing to the spleen (p<0.001, Figure 2C ), but not to lungs. (p=0.1457).
CXCR4 expression and homing of human mesenchymal stem cells
The consistent, albeit low, levels of homing to the bone marrow displayed by human MSC led us to investigate the possible contribution of CXCR4, as the bone marrow is reported to express high levels of SDF-1. We found that the surface expression of CXCR4 was low (2.3±1.8%, n=10) or absent (n=5) on all human MSC tested ( Figure  3A ). In contrast, human MSC harbored significant amounts of intracellular CXCR4 (63±12%, n=3, Figure  3A) , as previously reported. 31 Next we investigated whether CXCR4 receptors, despite their low expression on infused human MSC, did contribute to bone marrow homing. To do this, we used a phycoerythrin-cyanin 5 (PE-Cy5)-conjugated anti-CXCR4 monoclonal antibody to label human MSC that had homed to the bone marrow. We confirmed that the PE-Cy5-conjugated monoclonal antibody was able to stain surface CXCR4 molecules on PKH-labeled human MSC (Online Supplementary  Figure S2) . Bone marrow cells recovered from animals 24 hours after infusion of unmanipulated human MSC were incubated with PE-Cy5-conjugated anti-CXCR4 monoclonal antibody or the isotype control, washed and analyzed by flow cytometry. We found that bone marrowhomed human MSC, identified as PKH-bright cells (gated in Panel A, Figure 3B ) expressed significant levels of CXCR4 (28.8±8.1%, n=5), compared with levels on pre- infusion human MSC (panel B, Figure 3B ). This suggests that either human MSC upregulate intracellular CXCR4 in vivo, or there is preferential homing of a small population of human MSC expressing higher levels of CXCR4.
CXCR4 expression and in vitro migration of human mesenchymal stem cells
Human MSC were transduced with a bicistronic vector encoding CXCR4 and eGFP (MSC CXCR4 ), or the control vector encoding eGFP (MSC GFP ). Significant levels of transgene expression were achieved (43-96% CXCR4, 50-93% eGFP positive, Figure 4A ) and the expression was stable for up to 20 passages. CXCR4 expression on human MSC CXCR4 from five different donors was 41.8±9.8 (MCF) and 73.2±12.7 (% positive). Both human MSC GFP and human MSC CXCR4 expressed intracellular CXCR4 ( Figure 4A ). In vitro, unmanipulated human MSC migrated to SDF-1, as previously reported. 31 Human MSC CXCR4 (>80% CXCR4-positive) displayed significantly higher levels of migration to SDF-1 ( Figure 4B ). No further increase in migration occurred at SDF-1 concentrations >100 ng/mL.
Enforced CXCR4 expression does not alter homing in unconditioned recipients
We found no significant differences in bone marrow homing between eGFP-transduced (median 422/10 5 cells; range, 267-556), and unmanipulated human MSC (median 376/10 5 cells; range, 247-539), suggesting that lentiviral transduction did not affect homing. The presence of eGFP-expressing human MSC in murine tissues was confirmed by direct visualization of fluorescent cells in bone marrow trephine rolls (data not shown).
We next tested the in vivo homing of gene-modified human MSC expressing high (>85%) levels of CXCR4 (MSC CXCR4 ), using young animals (6-8 weeks), and unmanipulated or MSC GFP from the same donor as controls. To our surprise, enforced expression of CXCR4 had no effect on homing of human MSC to the bone marrow, spleen, liver or lungs of unconditioned β2m/NOD/SCID animals ( Figure 5A ). When we repeated these experiments in NOD/SCID animals, we found a small increase in homing of MSC CXCR4 to the spleen ( Figure  5B ), but no effect on bone marrow homing.
CXCR4 over-expression enhances in vivo homing in irradiated animals
It is possible that an effect of CXCR4 over-expression on homing would only be revealed in the context of tissue injury. We, therefore, repeated our experiments in sub-lethally irradiated hosts. Irradiation leads to loss of bone marrow cellularity (of up to 80%), so that the percentage of PKH-positive cells detected by flow cytometry is artefactually increased. The absolute numbers of PKH-positive human MSC detected per bone, however, remained unchanged (data not shown). Figure 6A ). Because irradiation reduces the total number of bone marrow cells, we also determined the number of PKH-positive cells/bone. These results confirmed the superior homing of CXCR4-expressing human MSC ( Figure 6B ). Similar effects of CXCR4 over-expression were also demonstrated for human MSC homing to the spleen ( Figure 6A ). The absolute number of human MSC homed to the spleen was also significantly higher for human MSC CXCR4 (p<0.05, Figure 6B ). 
Discussion
In this study we used a sensitive dye-labeling method to quantify the tissue biodistribution of human MSC after systemic injection in a xenograft model, and showed that a proportion of transplanted cells was capable of localizing into the bone marrow, spleen and lungs of unconditioned animals. A key observation reported here is that the efficiency of homing is critically influenced by the age of the recipient animal, and also declines with increased duration of cell culture. The adverse effect of the recipient's age on short-term homing in this model remains to be confirmed in other models, and in human recipients. It may, however, have important implications for clinical transplantation in elderly recipients. A decline in homing may be related to the down-regulation of stromal cellderived chemokines/cytokines during the aging process. The decline in homing efficiency with prolonged ex vivo culture of human bone marrow-derived MSC in this study using an unconditioned immunodeficient xenogeneic model is reminiscent of a similar previous report using murine MSC in a syngeneic model. 40 Many clinical applications require high doses of MSC, achievable only with considerable ex vivo expansion. A clearer under- standing of the effect of extended in vitro culture on adhesion and chemokine receptor expression, and on migratory capacity is needed. Importantly, our observations confirm a potential role for the CXCR4 receptor in the short-term homing behavior of systemically administered human MSC. While unmanipulated human MSC express low levels of surface CXCR4, cells that had localized to the bone marrow at 20 hours post-transplantation showed significant levels of expression. We demonstrate for the first time that enforced surface expression of CXCR4 by lentiviral gene transfer was able to enhance in vivo short-term homing, but only in the context of an irradiated model. The reported surface expression of CXCR4 on human MSC varies from almost negligible to 20-40%. 33, 34 Such variation may be related to differences in culture conditions. For example, CXCR4 is known to be upregulated when human MSC are exposed to cytokines, including insulin-like growth factor-1, 41 which is present in cell culture serum. Several studies now report that human MSC migrate in vitro in response to SDF-1, 31, 34 perhaps mediated by upregulation of intracellular CXCR4 molecules. Similarly, the localization of human MSC to the bone marrow, despite low surface expression of CXCR4, may be explained by upregulation of intracellular CXCR4 molecules to the cell surface in vivo, in response to cytokines, sheer forces, 42 or exposure to hypoxia. Similarly, upregulation of CXCR4 by cytokines in vitro may enhance short-term localization of MSC to the bone marrow of irradiated NOD/SCID animals. 44 In the present study we used a lentiviral system to stably over-express a functional CXCR4 receptor on human MSC and examined the effects on SDF-1-directed migration in vitro and on homing in vivo. Lentiviral vectors are well suited to these studies because their safety profile is better than that of onco-retroviral vectors. 45 Over-expression of CXCR4 on human MSC significantly promoted their migration in vitro, in confirmation of previous reports, 31, 46 but did not influence short-term homing to the bone marrow following systemic administration in unconditioned mice. CXCR4 expression is dynamic and regulated by cytokines, adhesion molecules, ligand-binding and proteolytic enzymes. 15, 28 Functional modulation by receptor internalization and trafficking, incorporation into lipid rafts, cleavage of both CXCR4 and SDF-1 by serine proteases and matrix metalloproteinases also occurs. 28, 47 It is not clear if, and how, lentivirally expressed surface molecules are subject to these physiological regulatory mechanisms.
Irradiation, and consequent tissue injury, leads to increased secretion of cytokines and chemokines such as SDF-1, and, in some models, to increased homing/engraftment of MSC. 48, 49 It is not surprising, therefore, that CXCR4-overexpressing human MSC demonstrate superior homing (compared with control human MSC) under these circumstances. What is perhaps surprising is that while more than 80% of infused cells express surface CXCR4 molecules, levels of homing remain below 1%. This may reflect the limited capacity of the system, or alternatively CXCR4-expressing human MSC may display increased localization to tissues other than the bone marrow and spleen. Lentivirally expressed receptors may not undergo physiological trafficking necessary for optimal function, as discussed above. Increased CXCR4 receptors on genetically modified human MSC may also affect the migratory response to other inflammatory or chemokinetic agents released following irradiation by receptor cross-talk. 50 In conclusion we report that multiple factors influence the in vivo homing of human MSC in this xenogeneic model. In vivo homing to the bone marrow and spleen is greater in younger animals. Enforced surface expression of CXCR4 by lentiviral gene transfer leads to increased in vitro migration to SDF-1, and enhanced homing in vivo but this effect is only marked in irradiated hosts. These factors should be taken into account when using in vivo models for pre-clinical evaluation of MSC-based therapies.
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